Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Dividends Paid - Common (2020 - 2025)

Pharma-Bio Serv's Dividends Paid - Common history spans 6 years, with the latest figure at $1.7 million for Q2 2025.

  • For Q2 2025, Dividends Paid - Common changed 0.13% year-over-year to $1.7 million; the TTM value through Oct 2025 reached $1.7 million, down 50.07%, while the annual FY2025 figure was $1.7 million, 0.13% changed from the prior year.
  • Dividends Paid - Common reached $1.7 million in Q2 2025 per PBSV's latest filing, roughly flat from $1.7 million in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $1.7 million in Q2 2021 to a low of $1.7 million in Q2 2025.
  • Average Dividends Paid - Common over 5 years is $1.7 million, with a median of $1.7 million recorded in 2022.
  • Peak YoY movement for Dividends Paid - Common: fell 0.18% in 2022, then dropped 0.02% in 2023.
  • A 5-year view of Dividends Paid - Common shows it stood at $1.7 million in 2021, then dropped by 0.18% to $1.7 million in 2022, then decreased by 0.02% to $1.7 million in 2023, then decreased by 0.09% to $1.7 million in 2024, then fell by 0.13% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for PBSV's Dividends Paid - Common are $1.7 million (Q2 2025), $1.7 million (Q2 2024), and $1.7 million (Q1 2024).